Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Metastatic Neoplasm: early-phase trial registry

2 of 2 indexed Metastatic Neoplasm trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Metastatic Neoplasm: 2 US clinical trials tracked, 2 recruiting.

Metastatic Neoplasm is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Oklahoma, running 1 of these trials.

Enrollment posture brief

Registry condition metastatic-neoplasm

OPEN 2 | RECR 100% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Metastatic Neoplasm (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Metastatic Neoplasm

Metastatic Neoplasm lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Metastatic Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Metastatic Neoplasm is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Metastatic Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

MK-8294 Drug
1 trials
Spine radiosurgery/stereotactic body radiation therapy high dose Radiation
1 trials
Spine radiosurgery/stereotactic body radiation therapy standard dose Radiation
1 trials
Conventional external beam radiation therapy dose (EBRT) Radiation
1 trials

US sites by state

Facility locations filed on Metastatic Neoplasm trials. A trial with sites in several states counts in each.

Oklahoma 1 trials
Maryland 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Metastatic Neoplasm page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metastatic Neoplasm condition card totals 2 registered trials; most-linked intervention MK-8294; top US site state Oklahoma. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.